Ultrasound Guided Hematoma Block in Distal Radius Fractures
Launched by FRISIUS MEDISCH CENTRUM · Jan 4, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage pain in patients with a specific type of wrist fracture, known as a distal radius fracture. The researchers want to see if using ultrasound guidance during a procedure called a hematoma block (which involves injecting a local anesthetic to numb the area) is more effective than the traditional method, which does not use ultrasound. This trial is currently looking for participants, and you may be eligible if you are 16 years or older and have a confirmed distal radius fracture that needs treatment.
If you join the study, you will receive either the ultrasound-guided hematoma block or the standard method to help relieve your pain. The researchers aim to understand which method works better so that future patients can benefit from improved pain management. It's important to note that certain conditions, like having cognitive issues or other serious injuries, may prevent some people from participating. Your safety and comfort are the top priority in this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 16 years
- * Confirmed fracture of the distal radius requiring closed reduction, defined as any off the following items(7):
- • \>10 degrees of dorsal angulation;
- • \>20 degrees of volar angulation;
- • \>2 mm step-off intra-articular;
- • \>3 mm radial shortening;
- • \>15 degrees radial inclination;
- • Translation and non-intact radio-carpal alignment in the lateral view
- • Significant translation in the posterior-anterior(PA)-view.
- Exclusion Criteria:
- • No informed consent can be given (cognitive impairment, severe dementia, no knowledge of Dutch language e.a.)
- • Neurovascular compromise or open fractures requiring (immediate) surgery or reduction.
- • First reduction already performed
- • Multi-trauma patients requiring other urgent procedures/tests or with respiratory or hemodynamical compromise
- • Pre-existent osteosynthesis material in situ in the affected arm
- • Skin injury (with exception of minor abrasions), local infection or recent burns hindering or contra-indicating the use of ultrasound and ultrasound gel
- • Allergy for local anesthetics
About Frisius Medisch Centrum
Frisius Medisch Centrum is a leading clinical research organization dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a commitment to excellence, Frisius Medisch Centrum collaborates with healthcare professionals, researchers, and regulatory bodies to design and implement rigorous studies across various therapeutic areas. Their state-of-the-art facilities and experienced team ensure high-quality data collection and analysis, driving the development of new treatments and therapies. Frisius Medisch Centrum is dedicated to maintaining the highest ethical standards while fostering a patient-centric approach in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeuwarden, Friesland, Netherlands
Patients applied
Trial Officials
Pieter Veenstra
Principal Investigator
Medisch Centrum Leeuwarden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported